Alan Kunz, AUD | |
117 E Kentucky St, Louisville, KY 40203-2793 | |
(502) 584-3571 | |
Not Available |
Full Name | Alan Kunz |
---|---|
Gender | Male |
Speciality | Qualified Audiologist |
Experience | 6 Years |
Location | 117 E Kentucky St, Louisville, Kentucky |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1649769464 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
231H00000X | Audiologist | (* (Not Available)) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ent Care Centers Pllc | 2961896832 | 21 |
Ent Care Centers Pllc | 2961896832 | 21 |
News Archive
A new study conducted by The Mind Research Network in Albuquerque, N.M., shows that neuroimaging data can predict the likelihood of whether a criminal will reoffend following release from prison.
Exelixis, Inc. today announced that the National Comprehensive Cancer Network updated its Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets.
The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. as its February 2010 "Stock to Study" and C.R. Bard, Inc. as its February 2010 "Undervalued Stock" for investors' informational and educational use.
Axios Mobile Assets Corporation today announced it has achieved FDA compliance for its proprietary bio-based trackable pallet and software technology. The solutions meet FDA standards for CFR 21 part 11 compliance based on the pallet's material composition, in accordance to the U.S. Federal Code of Regulation.
At least half of patients recovering from depression will experience a relapse, but there are currently no evidence-based tools to help GPs or other healthcare professionals to identify those at high risk.
› Verified 9 days ago
Provider Name | Edith & Henry Heuser Hearing Institute |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1881668663 PECOS PAC ID: 2062451610 Enrollment ID: O20050503000470 |
News Archive
A new study conducted by The Mind Research Network in Albuquerque, N.M., shows that neuroimaging data can predict the likelihood of whether a criminal will reoffend following release from prison.
Exelixis, Inc. today announced that the National Comprehensive Cancer Network updated its Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets.
The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. as its February 2010 "Stock to Study" and C.R. Bard, Inc. as its February 2010 "Undervalued Stock" for investors' informational and educational use.
Axios Mobile Assets Corporation today announced it has achieved FDA compliance for its proprietary bio-based trackable pallet and software technology. The solutions meet FDA standards for CFR 21 part 11 compliance based on the pallet's material composition, in accordance to the U.S. Federal Code of Regulation.
At least half of patients recovering from depression will experience a relapse, but there are currently no evidence-based tools to help GPs or other healthcare professionals to identify those at high risk.
› Verified 9 days ago
Provider Name | Ent Care Centers Pllc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1093381485 PECOS PAC ID: 2961896832 Enrollment ID: O20220218002399 |
News Archive
A new study conducted by The Mind Research Network in Albuquerque, N.M., shows that neuroimaging data can predict the likelihood of whether a criminal will reoffend following release from prison.
Exelixis, Inc. today announced that the National Comprehensive Cancer Network updated its Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets.
The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. as its February 2010 "Stock to Study" and C.R. Bard, Inc. as its February 2010 "Undervalued Stock" for investors' informational and educational use.
Axios Mobile Assets Corporation today announced it has achieved FDA compliance for its proprietary bio-based trackable pallet and software technology. The solutions meet FDA standards for CFR 21 part 11 compliance based on the pallet's material composition, in accordance to the U.S. Federal Code of Regulation.
At least half of patients recovering from depression will experience a relapse, but there are currently no evidence-based tools to help GPs or other healthcare professionals to identify those at high risk.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Alan Kunz, AUD 101 Burr Ridge Pkwy, Ste 150, Burr Ridge, IL 60527-0877 Ph: (708) 805-1677 | Alan Kunz, AUD 117 E Kentucky St, Louisville, KY 40203-2793 Ph: (502) 584-3571 |
News Archive
A new study conducted by The Mind Research Network in Albuquerque, N.M., shows that neuroimaging data can predict the likelihood of whether a criminal will reoffend following release from prison.
Exelixis, Inc. today announced that the National Comprehensive Cancer Network updated its Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets.
The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. as its February 2010 "Stock to Study" and C.R. Bard, Inc. as its February 2010 "Undervalued Stock" for investors' informational and educational use.
Axios Mobile Assets Corporation today announced it has achieved FDA compliance for its proprietary bio-based trackable pallet and software technology. The solutions meet FDA standards for CFR 21 part 11 compliance based on the pallet's material composition, in accordance to the U.S. Federal Code of Regulation.
At least half of patients recovering from depression will experience a relapse, but there are currently no evidence-based tools to help GPs or other healthcare professionals to identify those at high risk.
› Verified 9 days ago
Fawn E. Wujick, M.S. Audiologist Medicare: Medicare Enrolled Practice Location: 13403 Forest Springs Dr, Louisville, KY 40245 Phone: 502-693-1449 Fax: 188-851-1026 | |
Special Care Hearing Of Kentucky Llc Audiologist Medicare: Medicare Enrolled Practice Location: 12910 Shelbyville Rd, Louisville, KY 40243 Phone: 855-259-9183 Fax: 502-254-4069 | |
Mark Jeffrey Hales, MA CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4004 Dupont Cir, Ste 220, Louisville, KY 40207 Phone: 502-893-0159 | |
Brittany Ann Brose, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 401 E Chestnut St, Suite 710, Louisville, KY 40202 Phone: 502-583-8303 | |
Mr. Eric Scott Cahill, MS CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 982 Eastern Pkwy, Building B, Louisville, KY 40217 Phone: 502-595-4459 | |
Special Care Hearing Of Indiana Llc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 12910 Shelbyville Rd, Louisville, KY 40243 Phone: 855-259-9183 Fax: 502-254-4086 | |
Deanna S Brown, MS Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2944 Breckenridge Ln, Louisville, KY 40220 Phone: 502-893-0159 Fax: 502-213-3892 |